|
|
Article: Soligenix Appoints Robert J. Rubin, MD, to its Board of Directors.
- Article from:
- Biotech Week
- Article date:
- October 21, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Soligenix, Inc. (Soligenix or the Company), (BULLETIN BOARD: SNGX) , a late-stage biopharmaceutical company, announced that Robert J. Rubin, MD, has been appointed to its Board of Directors (see also Pharmaceuticals).
Dr. Rubin has had a distinguished career in the healthcare industry and government. Among his industry positions, Dr. Rubin served as president of the national health policy and management consulting firm The Lewin Group, Inc. (purchased by Quintiles Transnational Corp. in 1996), and its predecessor organizations, from 1987 to 2001. He also served as Medical Director of ValueRx, a pharmaceutical benefits company. Among his government positions, Dr. ...